Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
120 hedge funds and large institutions have $58.1M invested in Sanofi Contingent Value Rights in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 12 increasing their positions, 28 reducing their positions, and 13 closing their positions.
47% more capital invested
Capital invested by funds: $39.6M → $58.1M (+$18.5M)
31% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 13
3% more funds holding
Funds holding: 116 → 120 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
57% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonehill Capital Management
New York
|
+$3.5M |
| 2 |
PC
PointState Capital
New York
|
+$2.47M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$1.35M |
| 4 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$904K |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$750K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$1.97M |
| 2 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$1.68M |
| 3 |
NGA
New Generation Advisors
Manchester,
Massachusetts
|
-$1.55M |
| 4 |
BHMP
Bardin Hill Management Partners
New York
|
-$994K |
| 5 |
Millennium Management
New York
|
-$254K |
GCVRZ Hedge Fund Activity: Q4 2016 in Review
120 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2016, worth a combined $58.1M — up 47% from $39.6M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new GCVRZ positions and 13 closed out — a net gain of 4 holders — while 12 added to existing stakes and 28 trimmed.
The largest buyer was Stonehill Capital Management, adding an estimated $3.5M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $1.97M.
- 120 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2016, up from 116 in Q3 2016.
- Funds reported $58.1M of Sanofi Contingent Value Rights stock for Q4 2016, up 47% quarter-over-quarter.
- 17 funds opened new Sanofi Contingent Value Rights positions in Q4 2016 and 13 closed out, a net change of +4 holders.
- The largest Sanofi Contingent Value Rights buyer in Q4 2016 was Stonehill Capital Management, an estimated $3.5M added.
- The largest Sanofi Contingent Value Rights seller in Q4 2016 was TPG Group Holdings (SBS) Advisors, an estimated $1.97M sold.
Based on aggregated 13F filings for Q4 2016.